Citation Impact
Citing Papers
Unified Synthesis of Polycyclic Alkaloids by Complementary Carbonyl Activation**
2021 StandoutNobel
Catalytic enantioselective Reformatsky reaction with ketones
2008 StandoutNobel
Catalytic asymmetric synthesis of new halogenated chiral synthons
1997 StandoutNobel
Catalytic Asymmetric Three‐Component Synthesis of Homoallylic Amines
2013 StandoutNobel
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
2013
Effects of Fluorine Substitution on Drug Metabolism: Pharmacological and Toxicological Implications
1994
Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE 3 gene family)
1995
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
2006 Standout
Catalytic Enantioselective Reformatsky Reaction with Aldehydes
2008 StandoutNobel
Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: Search for anticancer agent
2011
Network medicine: a network-based approach to human disease
2010 Standout
Indoles — A promising scaffold for drug development
2016
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
2011 Standout
Cyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and function
1991
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Catalytic Functionalization of Indoles in a New Dimension
2009 Standout
Modern Synthetic Methods for Copper‐Mediated C(aryl)O, C(aryl)N, and C(aryl)S Bond Formation
2003 Standout
Click Chemistry: Diverse Chemical Function from a Few Good Reactions
2001 StandoutNobel
Catalyst‐Free N‐Arylation Using Unactivated Fluorobenzenes
2012
Bemoradan—a novel inhibitor of the rolipram-insensitive cyclic AMP phosphodiesterase from canine heart tissue
1991
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Highly Efficient and Mild Copper‐Catalyzed N‐ and C‐Arylations with Aryl Bromides and Iodides
2004
Modern Synthetic Methods for Fluorine‐Substituted Target Molecules
2004 Standout
A network view of disease and compound screening
2009
Catalytic CC, CN, and CO Ullmann‐Type Coupling Reactions
2009 Standout
Controlled Microwave Heating in Modern Organic Synthesis
2004 Standout
An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles
2013
Heterocyclic Carbenes: Synthesis and Coordination Chemistry
2008 Standout
Asymmetric Allylboration of Acyl Imines Catalyzed by Chiral Diols
2007
Copper-Mediated Coupling Reactions and Their Applications in Natural Products and Designed Biomolecules Synthesis
2008 Standout
Fluorine in medicinal chemistry
2007 Standout
Chan–Lam coupling reactions: synthesis of heterocycles
2012
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Thiazoles: having diverse biological activities
2011
Multicomponent Reactions with Isocyanides
2000 Standout
Synthesis and Biological Evaluation of Novel Pyridazinone-Based α4Integrin Receptor Antagonists
2006
The Reformatsky reaction in organic synthesis. Recent advances
2004
Peptidomimetics—Tailored Enzyme Inhibitors
1994
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Preparation of a novel series of phosphonate norstatine renin inhibitors
1994
Synthesis and Evaluation of No-Carrier-Added 8-Cyclopentyl-3-(3-[18F]fluoropropyl)-1-propylxanthine ([18F]CPFPX): A Potent and Selective A1-Adenosine Receptor Antagonist for in Vivo Imaging
2002
Characterization and pharmacological relevance of high affinity binding sites for [3H]LY186126, a cardiotonic phosphodiesterase inhibitor, in canine cardiac membranes.
1989
Complete N-1 Regiocontrol in the Formation of N-Arylimidazoles. Synthesis of the Active Site His-Tyr Side Chain Coupled Dipeptide of Cytochrome c Oxidase
2000
CuI catalyzed C–N bond forming reactions between aryl/heteroaryl bromides and imidazoles in [Bmim]BF4
2006
An efficient copper-catalyzed coupling of aryl halides with imidazoles
1999
Synthesis of chiral and bioactive fluoroorganic compounds
1993
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Ultrasound effect on the synthesis of 4-alkyl-(aryl)aminobenzaldehydes
2001
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
1995 Standout
An Efficient Diamine·Copper Complex-Catalyzed Coupling of Arylboronic Acids with Imidazoles
2000
Selected Patented Cross-Coupling Reaction Technologies
2006 Standout
Deep eutectic solvents (DESs) as eco-friendly and sustainable solvent/catalyst systems in organic transformations
2015
Deep Eutectic Solvents: A Review of Fundamentals and Applications
2020 Standout
Pyridazine derivatives. Part 33: Sonogashira approaches in the synthesis of 5-substituted-6-phenyl-3(2H)-pyridazinones
2003
Copper in cross-coupling reactions
2004 Standout
Rational Tuning of Fluorobenzene Probes for Cysteine‐Selective Protein Modification
2018 StandoutNobel
Green and Sustainable Solvents in Chemical Processes
2018 Standout
A Field Guide to Foldamers
2001 Standout
The Catalytic Asymmetric Aminohydroxylation of Unsaturated Phosphonates
1999 StandoutNobel
Microwave-Assisted Synthesis in Water as Solvent
2007 Standout
The [Cu(OH)·TMEDA]2Cl2-Catalyzed Coupling of Arylboronic Acids with Imidazoles in Water
2001
Aerobic Copper-Catalyzed Organic Reactions
2013 Standout
Click Chemistry: Diverse Chemical Function from a Few Good Reactions
2001 StandoutNobel
Catalytic Enantioselective Reformatsky Reaction with ortho-Substituted Diarylketones
2008 StandoutNobel
Mechanism and Scope of Base‐Controlled Catalyst‐Free N‐Arylation of Amines with Unactivated Fluorobenzenes
2016 StandoutNobel
Catalytic Asymmetric Conjugate Addition and Allylic Alkylation with Grignard Reagents
2008 StandoutNobel
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
Catalyst‐Free N‐Arylation Using Unactivated Fluorobenzenes
2012
Solid-phase synthesis and evaluation of libraries of substituted 4,5-dihydropyridazinones as vasodilator agents
2004
Rapid microwave-assisted solution phase synthesis of substituted 2-pyridone libraries
2004
Synthesis and pharmacological activity of some new pyridazinones
1992
Unsaturated Nitriles: Conjugate Additions of Carbon Nucleophiles to a Recalcitrant Class of Acceptors
2003
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
2018 Standout
From 2000 to Mid-2010: A Fruitful Decade for the Synthesis of Pyrazoles
2011 Standout
Catalytic Activities of Cu(II) Complexes with Nitrogen-Chelating Bidentate Ligands in the Coupling of Imidazoles with Arylboronic Acids
2001
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Aryl−Aryl Bond Formation One Century after the Discovery of the Ullmann Reaction
2002 Standout
Novel applications of carbon dioxide/MeOH for the synthesis of hydantoins and cyclic ureas via the Ugi reaction
2000
Syntheses and Structure−Activity Relationships of Novel Retinoid X Receptor Agonists
1998
The Copper-Mediated Cross-Coupling of Phenylboronic Acids and N-Hydroxyphthalimide at Room Temperature: Synthesis of Aryloxyamines
2000 StandoutNobel
Methods for the synthesis of gem-difluoromethylene compounds
1996
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Synthesis of Novel Angular Heterocyclic Lignans by an InCl3‐Catalyzed Friedel–Crafts‐Type Cyclization
2008
Asymmetric Synthesis of Chiral Organofluorine Compounds: Use of Nonracemic Fluoroiodoacetic Acid as a Practical Electrophile and Its Application to the Synthesis of Monofluoro Hydroxyethylene Dipeptide Isosteres within a Novel Series of HIV Protease Inhibitors
2001
Works of Ila Sircar being referenced
Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors
1992
Synthesis and SAR of N-Benzoyl-?-Biphenylalanine Derivatives: Discovery of TR-14035, A Dual α4β7/α4β1 Integrin Antagonist
2002
2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists
2007
Discovery and structure–activity relationship studies of indole derivatives as liver X receptor (LXR) agonists
2007
Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activity
1987
Cardiotonic agents. 8. Selective inhibitors of adenosine 3',5'-cyclic phosphate phosphodiesterase III. Elaboration of a five-point model for positive inotropic activity
1987
Synthesis and structure–activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors
2007
Derivatives of 5-[[1-4(4-carboxybenzyl)imidazolyl]methylidene]hydantoins as orally active angiotensin II receptor antagonists
1995
Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors
1992
New inhibitors of human renin that contain novel replacements at the P2 site
1991
Cardiotonic agents. 5. 1,2-Dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-6-methyl-2-oxo-3-pyridinecarbonitriles and related compounds. Synthesis and inotropic activity
1987
Phenylenebis(oxy)bis[2,2-dimethylpentanoic acids]: agents that elevate high-density lipoproteins
1983
An improved and efficient synthesis of 2-substituted 1,4-dihydropyridine derivatives via regiospecific bromination
1988
Cardiotonic agents. 4. Synthesis and biological evaluation of N-substituted 2,4,4a,5-tetrahydro-3H-indeno[1,2-c]pyridazin-3-ones: rigid structures derived from CI-930 and analogs
1986
Cardiotonic agents. 3. Synthesis and biological activity of novel 6-(substituted 1H-imidazol-4(5)-yl)-3(2H)-pyridazinones
1986
Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents
1985
Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure
1984
Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
1995